Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$292.75 - $367.01 $548,906 - $688,143
-1,875 Closed
0 $0
Q1 2021

May 12, 2021

SELL
$260.64 - $382.12 $84.9 Million - $124 Million
-325,596 Reduced 99.43%
1,875 $653,000
Q4 2020

Feb 16, 2021

SELL
$221.31 - $316.61 $30.8 Million - $44 Million
-139,124 Reduced 29.82%
327,471 $84.6 Million
Q3 2020

Nov 16, 2020

BUY
$189.18 - $286.44 $20.8 Million - $31.4 Million
109,754 Added 30.76%
466,595 $134 Million
Q2 2020

Aug 11, 2020

BUY
$123.9 - $195.41 $2.29 Million - $3.61 Million
18,475 Added 5.46%
356,841 $67.2 Million
Q1 2020

May 14, 2020

BUY
$121.84 - $173.19 $20.9 Million - $29.7 Million
171,443 Added 102.71%
338,366 $41.7 Million
Q4 2019

Feb 13, 2020

SELL
$115.78 - $208.34 $11.3 Million - $20.3 Million
-97,309 Reduced 36.83%
166,923 $27.7 Million
Q3 2019

Nov 14, 2019

BUY
$120.61 - $148.29 $1.02 Million - $1.25 Million
8,416 Added 3.29%
264,232 $32.4 Million
Q2 2019

Aug 14, 2019

BUY
$113.99 - $146.86 $1.71 Million - $2.2 Million
14,958 Added 6.21%
255,816 $31.7 Million
Q1 2019

May 15, 2019

SELL
$122.82 - $151.83 $532,915 - $658,790
-4,339 Reduced 1.77%
240,858 $31.8 Million
Q4 2018

Feb 14, 2019

BUY
$107.01 - $175.15 $16.2 Million - $26.5 Million
151,354 Added 161.28%
245,197 $34.4 Million
Q3 2018

Nov 14, 2018

BUY
$152.62 - $189.66 $14.3 Million - $17.8 Million
93,843 New
93,843 $16.2 Million

Others Institutions Holding BGNE

About BeiGene, Ltd.


  • Ticker BGNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,700,000
  • Market Cap $18.3B
  • Description
  • BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...
More about BGNE
Track This Portfolio

Track Sands Capital Management, LLC Portfolio

Follow Sands Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sands Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sands Capital Management, LLC with notifications on news.